Clinical Trials on Cardiovascular Diseases (CVD) in Japan

Total 6978 results

Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Congestive Heart Failure

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

Chronic Heart Failure

Japan
Kurashiki Central Hospital

Unknown

Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience (BEGIN)

Coronary Stenosis

Japan
Okayama University
National Cerebral and Cardiovascular Center

Completed

Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology (TICAP)

Heart Failure | Hypoplastic Left Heart Syndrome | Single Ventricle

Japan
Takeda

Completed

Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"

Hypertension

Japan
Takeda

Completed

Azilsartan Tablets Special Drug Use Surveillance: Long-term Use

Hypertension

Japan
Kitakyushu-Tsuyazaki Hospital

Completed

Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study

Hypertension

Japan
Kurume University

Completed

Morning Hypertension and Preminent Therapy Study

Hypertension

Japan
Japan Heart Foundation

Completed

Japan Morning Surge-1 Study

Hypertension

Japan
Hyogo College of Medicine

Withdrawn

Relationship Between Pressure and Flow Velocity on Coronary Physiology

Coronary Stenosis

Japan
Yokohama City University Medical Center

Completed

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Hypertension

Japan
Nara Medical University

Completed

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering (NARA)

Hypertension

Japan
Okayama University

Completed

Effect of Midazolam on White-coat Hypertensive Dental Patients

Transient Hypertension

Japan
Kyoto University, Graduate School of Medicine

Completed

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study (STOPDAPT-2)

Coronary Artery Disease

Japan
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Fujita Health University

Unknown

Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation (MISTIC-1)

Coronary Artery Disease

Japan
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
Otsuka Medical Devices Co., Ltd. Japan

Active, not recruiting

Clinical Study of an Ultrasound Renal Denervation System in Patients With Heart Failure

Chronic Heart Failure

Japan
Biotronik SE & Co. KG

Completed

A Prospective Pilot Study (BIO|SELECT Pilot)

Heart Failure

Japan
Demand Investigators

Unknown

Diastolic Heart Failure Management by Nifedipine (DEMAND)

Diastolic Heart Failure

Japan
Bayer
Janssen Research & Development, LLC

Not yet recruiting

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Children | Congenital Heart Disease | Prevention of Venous Thromboembolism | Fontan Procedure

Japan
Kyoto University
Yamaguchi University Hospital

Completed

Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Ex JAPAN-ACS)

Acute Coronary Syndrome | Cardiovascular Events | Statin | Intravascular Ultrasound | Coronary Plaque

Japan
Takeshi Morimoto

Completed

Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial (ReACT)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Short and Optimal Duration of Dual Antiplatelet Therapy Study (STOPDAPT)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial (RESET)

Coronary Artery Disease

Japan
Kumamoto University

Completed

Impaired Peripheral Endothelial Function and In-stent Restenosis

Coronary Artery Disease

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan (CHOICE)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial (NEXT)

Coronary Artery Disease

Japan
Kumamoto University

Completed

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Coronary Artery Disease | Cardiac CT

Japan
Nagoya University

Unknown

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Buerger Disease | Arteriosclerosis Obliterans

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Essential Hypertension (ESAX-HTN)

Essential Hypertension

Japan
Takeshi Morimoto

Completed

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (ONCO DVT)

Neoplasms | Venous Thrombosis | Anticoagulant

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Hypertension

Japan
Conor Medsystems
Getz Pharma

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Coronary Disease

Japan
Kumamoto University
Japan Heart Foundation; The 4C trial bureau

Completed

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Coronary Artery Disease | Hypertension

Japan
Hyogo College of Medicine

Withdrawn

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (ASSESS)

Coronary Artery Disease | Atherosclerosis

Japan
Hiroshima University

Unknown

Plaque Registration and Event Detection In Computed Tomography (PREDICT)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis

Japan
Translational Research Center for Medical Innovation...
Nippon Medical School, Musashi Kosugi Hospital

Completed

Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure (MT FUJI)

Heart Failure

Japan
Okayama University

Completed

Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services (RAPA-JMCS)

Atherosclerosis | Periodontal Disease

Japan
Aichi Gakuin University

Unknown

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

Atherosclerosis

Japan
Kumamoto University

Completed

Assessments of Thrombus Formation in TAVI

Aortic Valve Stenosis | Heart Valve Diseases

Japan
Kumamoto University

Completed

Endothelial Dysfunction and Coronary Artery Spasm

Coronary Vasospasm

Japan
Assiut University
Wakayama Medical University

Completed

Impact of OCT Imaging on Decision Making During PCI in ACS Patients

Acute Coronary Syndrome

Japan
Yokohama City University Medical Center

Completed

Endothelial Dysfunction and Plaque Vulnerability

Acute Coronary Syndrome

Japan
Juntendo University
Japan Heart Foundation

Completed

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

Hypertension | Coronary Atherosclerosis

Japan
W.L.Gore & Associates

Completed

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

Peripheral Arterial Disease

Japan
Alnylam Pharmaceuticals

Recruiting

A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Mild to Moderate Hypertension

Japan
Hyogo College of Medicine
Ministry of Health, Labour and Welfare, Japan

Completed

Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure (J-MELODIC)

Congestive Heart Failure

Japan
Ministry of Health, Labour and Welfare, Japan
Japan Cardiovascular Research Foundation

Unknown

Hypertension Control Based on Home Blood Pressure

Hypertension

Japan

3

Subscribe